International Business

International Strategy

Expanding our global footprint to provide safer, more effective, and more accessible treatment regimens for HIV patients worldwide.

Aidea Pharma adheres to the development strategy of "Innovation-Driven, Global Layout," focusing on two core areas—anti-HIV drugs and human-derived proteins. The Company is committed to building a globally competitive product pipeline and industrial capabilities, actively advancing international registrations and overseas commercialization, and striving to bring Chinese innovative drugs to more patients around the world.

Product Globalization

Leveraging its independent innovation capabilities, the Company is accelerating the internationalization of its core products, actively pursuing registrations and commercial partnerships in key regions such as Africa and Southeast Asia, while conducting early regulatory communications and clinical layout in European and U.S. markets.
Commercialization Milestones

In 2025, the Company's core anti-HIV innovative drug Aitribond ^® was approved for marketing in Zanzibar, marking a significant step forward in the international commercialization of China's independently developed anti-HIV innovative drugs.
Deepening International Collaboration

Looking ahead, Aidea Pharma will continue to deepen international collaboration to provide safer, more effective, and more accessible treatment regimens for patients worldwide.

Global Layout

产品已在11个国家/区域启动注册
产品已在1个国家/区域完成注册
产品已在1个国家形成商业销售

International Exchange & Cooperation

Aidea Pharma is deeply engaged in academic exchanges, regulatory dialogues, and international cooperation in the global HIV response. The Company continuously publishes research findings at premier international conferences, actively expands its global partnership network, and demonstrates the scientific strength and international influence of Chinese innovative drugs.

Open Cooperation

Aidea Pharma consistently embraces an open cooperation approach and welcomes global partners to engage in in-depth discussions on products, technologies, and international market expansion, jointly exploring diverse opportunities for international collaboration.

 info@aidea.com.cn

 9/F, Weimei Building, No. 8 Kehui 3rd Street, Huangpu District, Guangzhou, Guangdong, China